(19)
(11) EP 3 979 997 A1

(12)

(43) Date of publication:
13.04.2022 Bulletin 2022/15

(21) Application number: 20729803.5

(22) Date of filing: 05.06.2020
(51) International Patent Classification (IPC): 
A61K 31/138(2006.01)
A61K 31/343(2006.01)
A61K 35/34(2015.01)
A61P 9/06(2006.01)
 A61K 31/167(2006.01)
A61K 31/18(2006.01)
A61K 45/06(2006.01)
C12N 5/077(2010.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/167; A61K 31/138; A61K 31/343; A61P 9/06; A61K 45/06; C12N 5/0657; A61K 35/34; A61K 31/18
 
C-Sets:
  1. A61K 31/138;
  2. A61K 31/167;
  3. A61K 31/343;
  4. A61K 31/18;
(86) International application number:
PCT/EP2020/065703
(87) International publication number:
WO 2020/245409 (10.12.2020 Gazette 2020/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 06.06.2019 EP 19178657

(71) Applicant: Novo Nordisk A/S
2880 Bagsværd (DK)

(72) Inventors:
  • KEMPF, Henning
    2880 Bagsværd (DK)
  • RASMUSSEN, Salka, Elbøl
    2880 Bagsværd (DK)
  • RØPCKE, Diana, Mathilde
    2880 Bagsværd (DK)

   


(54) APPLICATION OF ANTIARRHYTHMIC AGENTS TO STEM CELL DERIVED CARDIOMYOCYTES AND USES THEREOF